China FDA approves clinical trials for β-aminoarteether maleate for treatment of Lupus erythematosus (SLE)

SLE occurs 10x more often among Asians as compared to Westerners, and 2.2 million people are said tob e infected in China, India and Mexico. β-Aminoarteether maleate is an active ingredient of Artemisia annua.

CAS news release, May 21, 2015

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny